1. Home
  2. ONMD vs DYAI Comparison

ONMD vs DYAI Comparison

Compare ONMD & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.89

Market Cap

34.7M

Sector

N/A

ML Signal

HOLD

Logo Dyadic International Inc.

DYAI

Dyadic International Inc.

HOLD

Current Price

$0.74

Market Cap

30.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
DYAI
Founded
2006
1979
Country
United States
United States
Employees
22
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
30.8M
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
ONMD
DYAI
Price
$0.89
$0.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
682.7K
102.6K
Earning Date
05-13-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,090,345.00
Revenue This Year
N/A
$144.41
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.65
52 Week High
$4.22
$1.43

Technical Indicators

Market Signals
Indicator
ONMD
DYAI
Relative Strength Index (RSI) 55.91 48.95
Support Level $0.81 N/A
Resistance Level $0.89 $0.97
Average True Range (ATR) 0.10 0.10
MACD 0.01 -0.01
Stochastic Oscillator 68.03 36.78

Price Performance

Historical Comparison
ONMD
DYAI

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: